Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

BioStock: Curasight strengthens the investor base with Curium and Pentwater

Curasight

Curasight has announced a rights issue aiming to raise approximately 100 million DKK. The company has already secured approximately DKK 65 million in financing, comprising around DKK 47 million through pre-subscriptions and guarantee commitments in the rights issue. In addition, Curasight has secured and renegotiated approximately DKK 18 million in loan facilities. Nearly half of the secured capital in the rights issue is attributable to support from Curium International Trading B.V and Pentwater Capital Management Europe LLP. Proceeds will be used to secure clinical development towards key milestones, including the completion of phase II for the company's diagnostic platform uTRACE in prostate cancer and phase I for the therapeutic platform uTREAT in aggressive brain cancer  - glioblastoma. We spoke with CEO Ulrich Krasilnikoff to learn more.

Read the interview with Ulrich Krasilnikoff at biostock.se:

https://www.biostock.se/en/2025/04/curasight-strengthens-the-investor-base-with-curium-and-pentwater/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Our team
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet